Preeclampsia is associated with compromised maternal synthesis of long-chain polyunsaturated fatty acids, leading to offspring deficiency

Hypertension

Volumn 60, Issue 4, 2012, Pages 1078-1085

  MacKay, Vanessa A ^a   Huda, Shahzya S ^a   Stewart, Frances M ^a   Tham, Kahmeng ^a   McKenna, Louise A ^a   Martin, Iain ^a   Jordan, Fiona ^a   Brown, E Ann ^a   Hodson, Leanne ^b   Greer, Ian A ^a   Meyer, Barbara J ^c   Freeman, Dilys J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

fatty acid; intrauterine growth restriction; preeclampsia; pregnancy

Indexed keywords

ACYL COENZYME A DESATURASE 1; ADIPONECTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LEPTIN; LINOLEOYL COENZYME A DESATURASE; MESSENGER RNA; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; TRIACYLGLYCEROL; VERY LONG CHAIN FATTY ACID;

ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTE; FATTY ACID METABOLISM; FEMALE; GENE EXPRESSION; HUMAN; INTRAUTERINE GROWTH RETARDATION; LIPID COMPOSITION; LIPID METABOLISM; MAJOR CLINICAL STUDY; PLACENTAL TRANSFER; PREECLAMPSIA; PRIORITY JOURNAL; SUBCUTANEOUS FAT; THIRD TRIMESTER PREGNANCY; TRIACYLGLYCEROL BLOOD LEVEL;

FATTY ACIDS, UNSATURATED; FEMALE; FETAL GROWTH RETARDATION; HUMANS; PRE-ECLAMPSIA; PREGNANCY;

EID: 84866559480     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.197897     Document Type: Article

References (37)

1. Sattar N, Gaw A, Packard CJ, Greer IA. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre-eclampsia. Br J Obstet Gynaecol. 1996;103:614-620.
2. Jarvie E, Hauguel-de-Mouzon S, Nelson SM, Sattar N, Catalano PM, Freeman DJ. Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clin Sci (Lond). 2010;119:123-129.
3. Videla LA, Rodrigo R, Araya J, Poniachik J. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease. Free Radic Biol Med. 2004;37:1499-1507.
4. Diderholm B, Stridsberg M, Nordén-Lindeberg S, Gustafsson J. Decreased maternal lipolysis in intrauterine growth restriction in the third trimester. BJOG. 2006;113:159-164.
5. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N. Divergent metabolic and vascular phenotypes in pre-eclampsia and intrauterine growth restriction: relevance of adiposity. J Hypertens. 2004;22:2177-2183.
6. Cetin I, Giovannini N, Alvino G, Agostoni C, Riva E, Giovannini M, Pardi G. Intrauterine growth restriction is associated with changes in polyunsaturated fatty acid fetal-maternal relationships. Pediatr Res. 2002;52:750-755.
7. Mahomed K, Williams MA, King IB, Mudzamiri S, Woelk GB. Erythrocyte omega-3, omega-6 and trans fatty acids in relation to risk of preeclampsia among women delivering at Harare Maternity Hospital, Zimbabwe. Physiol Res. 2007;56:37-50.
8. Ogburn PL Jr, Williams PP, Johnson SB, Holman RT. Serum arachidonic acid levels in normal and preeclamptic pregnancies. Am J Obstet Gynecol. 1984;148:5-9.
9. Ortega-Senovilla H, Alvino G, Taricco E, Cetin I, Herrera E. Enhanced circulating retinol and non-esterifed fatty acids in pregnancies complicated with intrauterine growth restriction. Clin Sci. 2010;118:351-358.
10. Arab L. Biomarkers of fat and fatty acid intake. J Nutr. 2003;133: 925S-932S.
11. Makrides M, Gibson RA. Long-chain polyunsaturated fatty acid requirements during pregnancy and lactation. Am J Clin Nutr. 2000;71(1 suppl): 307S-311S.
12. Al MD, van Houwelingen AC, Kester AD, Hasaart TH, de Jong AE, Hornstra G. Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br J Nutr. 1995;74:55-68.
13. Cetin I, Koletzko B. Long-chain omega-3 fatty acid supply in pregnancy and lactation. Curr Opin Clin Nutr Metab Care. 2008;11:297-302.
14. Stewart F, Rodie VA, Ramsay JE, Greer IA, Freeman DJ, Meyer BJ. Longitudinal assessment of erythrocyte fatty acid composition throughout pregnancy and post partum. Lipids. 2007;42:335-344.
15. Huda SS SN, Freeman DJ. Lipoprotein metabolism and vascular complications in pregnancy. Clin Lipidol. 2009;4:91-102.
16. Cunningham P, McDermott L. Long chain PUFA transport in human term placenta. J Nutr. 2009;139:636-639.
17. Campbell FM, Clohessy AM, Gordon MJ, Page KR, Dutta-Roy AK. Uptake of long chain fatty acids by human placental choriocarcinoma (BeWo) cells: role of plasma membrane fatty acid-binding protein. J Lipid Res. 1997;38:2558-2568.
18. Larqué E, Krauss-Etschmann S, Campoy C, Hartl D, Linde J, Klingler M, Demmelmair H, Caño A, Gil A, Bondy B, Koletzko B. Docosahexaenoic acid supply in pregnancy affects placental expression of fatty acid transport proteins. Am J Clin Nutr. 2006;84:853-861.
19. Xu LZ, Sánchez R, Sali A, Heintz N. Ligand specifcity of brain lipid-binding protein. J Biol Chem. 1996;271:24711-24719.
20. Lipid Research Clinics Program. Lipid and Lipoprotein Analysis. Manual of Laboratory Operations. Vol. 1. Bethesda, MD: Department of Health, Education and Welfare, National Institutes of Health; 1974:Publication No. 75-628.
21. Packard CJ, O'Reilly DS, Caslake MJ, McMahon AD, Ford I, Cooney J, Macphee CH, Suckling KE, Krishna M, Wilkinson FE, Rumley A, Lowe GD. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med. 2000;343:1148-1155.
22. Evans K, Burdge GC, Wootton SA, Clark ML, Frayn KN. Regulation of dietary fatty acid entrapment in subcutaneous adipose tissue and skeletal muscle. Diabetes. 2002;51:2684-2690.
23. Catalano PM, Presley L, Minium J, Hauguel-de Mouzon S. Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care. 2009;32:1076-1080.
24. Pardo IM, Geloneze B, Tambascia MA, Barros AA. Inverse relationship between cord blood adiponectin concentrations and the number of cigarettes smoked during pregnancy. Diabetes Obes Metab. 2005;7:144-147.
25. Stoll-Becker S, Kreuder J, Reiss I, Etspüler J, Blum WF, Gortner L. Infuence of gestational age and intrauterine growth on leptin concentrations in venous cord blood of human newborns. Klin Padiatr. 2003; 215:3-8.
26. Hauth JC, Clifton RG, Roberts JM, Myatt L, Spong CY, Leveno KJ, Varner MW, Wapner RJ, Thorp JM Jr, Mercer BM, Peaceman AM, Ramin SM, Carpenter MW, Samuels P, Sciscione A, Tolosa JE, Saade G, Sorokin Y, Anderson GD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal insulin resistance and preeclampsia. Am J Obstet Gynecol. 2011;204:327.e1-327.e6.
27. Rodie VA, Freeman DJ, Sattar N, Greer IA. Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis. 2004;175:189-202.
28. Ehrenberg HM, Dierker L, Milluzzi C, Mercer BM. Low maternal weight, failure to thrive in pregnancy, and adverse pregnancy outcomes. Am J Obstet Gynecol. 2003;189:1726-1730.
29. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res. 2008;47:348-380.
30. Carter JP, Furman T, Hutcheson HR. Preeclampsia and reproductive performance in a community of vegans. South Med J. 1987;80:692-697.
31. Fikree FF, Berendes HW, Midhet F, D'Souza RM, Hussain R. Risk factors for intrauterine growth retardation: results of a community-based study from Karachi. J Pak Med Assoc. 1994;44:30-34.
32. Lakin V, Haggarty P, Abramovich DR, Ashton J, Moffat CF, McNeill G, Danielian PJ, Grubb D. Dietary intake and tissue concentration of fatty acids in omnivore, vegetarian and diabetic pregnancy. Prostaglandins Leukot Essent Fatty Acids. 1998;59:209-220.
33. Fokkema MR, Smit EN, Martini IA, Woltil HA, Boersma ER, Muskiet FA. Assessment of essential fatty acid and omega3-fatty acid status by measurement of erythrocyte 20:3omega9 (Mead acid), 22:5omega6/20:4omega6 and 22:5omega6/22:6omega3. Prostaglandins Leukot Essent Fatty Acids. 2002;67:345-356.
34. Oken E, Kleinman KP, Olsen SF, Rich-Edwards JW, Gillman MW. Associations of seafood and elongated n-3 fatty acid intake with fetal growth and length of gestation: results from a US pregnancy cohort. Am J Epidemiol. 2004;160:774-783.
35. Szajewska H, Horvath A, Koletzko B. Effect of n-3 long-chain polyun-saturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2006;83:1337-1344.
36. Flachs P, Mohamed-Ali V, Horakova O, Rossmeisl M, Hosseinzadeh-Attar MJ, Hensler M, Ruzickova J, Kopecky J. Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia. 2006;49:394-397.
37. Krebs JD, Browning LM, McLean NK, Rothwell JL, Mishra GD, Moore CS, Jebb SA. Additive benefts of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int J Obes (Lond). 2006;30:1535-1544.